Provided by Tiger Fintech (Singapore) Pte. Ltd.

Phathom Pharmaceuticals

10.49
-0.0144-0.14%
Volume:32.97K
Turnover:346.83K
Market Cap:730.30M
PE:-2.02
High:10.70
Open:10.58
Low:10.40
Close:10.50
Loading ...

Phathom Pharmaceuticals Announces FDA Correction to Orange Book Listing, Confirming 10 Years of Regulatory Exclusivity for Voquezna® (Vonoprazan) Tablets Through May 3, 2032

THOMSON REUTERS
·
16 Jun

Phathom Pharmaceuticals Secures 10-Year Regulatory Exclusivity for VOQUEZNA® Tablets Following FDA Correction

Reuters
·
16 Jun

Phathom Pharmaceuticals Inc. Concluded Its Annual Stockholders Meeting

Reuters
·
10 Jun

Phathom Pharmaceuticals price target raised to $17 from $12 at Craig-Hallum

TIPRANKS
·
09 Jun

Phathom Pharmaceuticals Price Target Maintained With a $20.00/Share by HC Wainwright & Co.

Dow Jones
·
09 Jun

Phathom Pharmaceuticals Gains FDA Approval for VOQUEZNA® Exclusivity

TIPRANKS
·
07 Jun

Phathom Pharmaceuticals Gains Momentum with FDA Approval and Market Exclusivity for Voquezna

TIPRANKS
·
07 Jun

Phathom Pharmaceuticals Is Maintained at Buy by Needham

Dow Jones
·
07 Jun

Needham sees FDA’s positive CP ruling as best-case outcome for Phathom

TIPRANKS
·
07 Jun

BUZZ-U.S. STOCKS ON THE MOVE-WEC Energy, FuelCell Energy, Phathom Pharma

Reuters
·
07 Jun

Top Midday Gainers

MT Newswires Live
·
07 Jun

Phathom Pharmaceuticals price target raised to $29 from $23 at Cantor Fitzgerald

TIPRANKS
·
07 Jun

BUZZ-Phathom Pharma soars after FDA grants 10-year exclusivity shield for stomach drug

Reuters
·
07 Jun

Phathom says FDA to correct Orange Book for Voquenza exclusivity

TIPRANKS
·
07 Jun

Phathom Pharmaceuticals Secures FDA Approval for 10-Year Regulatory Exclusivity for VOQUEZNA® Tablets

Reuters
·
07 Jun

Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for Voquezna® (Vonoprazan) Tablets Through May 3, 2032

THOMSON REUTERS
·
07 Jun

Director’s Bold Move: Phathom Pharmaceuticals Stock Purchase

TIPRANKS
·
24 May

Director James N. Topper Reports Acquisition of Common Shares in Phathom Pharmaceuticals Inc

Reuters
·
24 May

Phathom Pharmaceuticals Inc. Set to Participate in Goldman Sachs Annual Global Healthcare Conference 2025

Reuters
·
15 May

Director James N. Topper Reports Acquisition of Common Shares in Phathom Pharmaceuticals Inc

Reuters
·
14 May